Synthesis of proteochondroitin sulfate by normal, nanomelic, and 5-bromodeoxyuridine-treated chondrocytes in cell culture.
D000818:Animals; D001848:Bone Diseases, Developmental / Q000235:genetics / Q000378:metabolism / Q000662:veterinary*; D001973:Bromodeoxyuridine / Q000494:pharmacology*; D002247:Carbon Isotopes; D002356:Cartilage / Q000187:drug effects / Q000378:metabolism*; D002478:Cells, Cultured; D002642:Chick Embryo; D002807:Chondroitin / Q000032:analysis / Q000096:biosynthesis* / Q000378:metabolism; D002845:Chromatography; D006821:Hyaluronoglucosaminidase / Q000378:metabolism; D009088:Mucoproteins / Q000032:analysis / Q000096:biosynthesis* / Q000378:metabolism; D011201:Poultry Diseases / Q000235:genetics / Q000378:metabolism*; D011402:Pronase / Q000378:metabolism; D013431:Sulfates / Q000378:metabolism; D013460:Sulfur Isotopes; D014316:Tritium
D002247:Carbon Isotopes; D009088:Mucoproteins; D013431:Sulfates; D013460:Sulfur Isotopes; D014316:Tritium; D002807:Chondroitin; D006821:Hyaluronoglucosaminidase; D011402:Pronase; D001973:Bromodeoxyuridine